Dr Gerhard Mann Artelac Rebalance Ophthalmic Solution Singapore - English - HSA (Health Sciences Authority)

dr gerhard mann artelac rebalance ophthalmic solution

bausch & lomb (singapore) private limited - ophthalmology - dr gerhard mann artelac® rebalance ophthalmic solution is best suited for use to relieve and calm persistent dry eye symptoms due to chronic tear deficiency.

Dr. Gerhard Mann Artelac Rebalance Eye Drop Singapore - English - HSA (Health Sciences Authority)

dr. gerhard mann artelac rebalance eye drop

bausch & lomb (singapore) private limited - ophthalmology - eye lubricant and contact lens wetting.

Dr Reddy's Omeprazole New Zealand - English - Medsafe (Medicines Safety Authority)

dr reddy's omeprazole

dr reddy's new zealand limited - omeprazole 20mg;   - modified release capsule - 20 mg - active: omeprazole 20mg   excipient: crospovidone gelatin hypromellose isopropyl alcohol magnesium stearate mannitol meglumine methacrylic acid - ethyl acrylate copolymer opacode black s-1-27794 poloxamer povidone purified water triethyl citrate

Bortezomib - Dr. Reddy's New Zealand - English - Medsafe (Medicines Safety Authority)

bortezomib - dr. reddy's

dr reddy's new zealand limited - bortezomib 3.5mg (as a mannitol boronic ester) - powder for injection - 3.5 mg - active: bortezomib 3.5mg (as a mannitol boronic ester) excipient: mannitol - bortezomib - dr. reddy's, in combination with melphalan and prednisone, is indicated for the treatment of patients with previously untreated multiple myeloma, who are not suitable for high dose chemotherapy. bortezomib - dr. reddy's as part of combination therapy, is indicated for induction therapy prior to high dose chemotherapy with autologous stem cell rescue for patients under 65 years of age with previously untreated multiple myeloma. bortezomib - dr. reddy's is also indicated for the treatment of multiple myeloma patients who have received at least one prior therapy, and who have progressive disease.

DASATINIB DR.REDDY'S dasatinib 100 mg film coated tablet blister pack Australia - English - Department of Health (Therapeutic Goods Administration)

dasatinib dr.reddy's dasatinib 100 mg film coated tablet blister pack

dr reddys laboratories australia pty ltd - dasatinib propylene glycol, quantity: 116 mg (equivalent: dasatinib, qty 100 mg) - tablet, film coated - excipient ingredients: hydrogenated castor oil; lactose; silicon dioxide; magnesium stearate; croscarmellose sodium; microcrystalline cellulose; titanium dioxide; hypromellose; triacetin - dasatinib dr.reddy's is indicated for the treatment of adults aged 18 years or over with: ? newly diagnosed philadelphia chromosome positive (ph+) chronic myeloid leukaemia in the chronic phase. ? chronic, accelerated or myeloid or lymphoid blast phase chronic myeloid leukaemia with resistance or intolerance to prior therapy including imatinib. ? newly diagnosed philadelphia chromosome positive acute lymphoblastic leukaemia integrated with chemotherapy. ? philadelphia chromosome positive acute lymphoblastic leukaemia with resistance or intolerance to prior therapy.,dasatinib dr.reddy's is indicated for the treatment of paediatric patients with: ? ph+ cml in the chronic phase. ? newly diagnosed ph+ all in combination with chemotherapy.

DASATINIB DR.REDDY'S dasatinib 20 mg film coated tablet blister pack Australia - English - Department of Health (Therapeutic Goods Administration)

dasatinib dr.reddy's dasatinib 20 mg film coated tablet blister pack

dr reddys laboratories australia pty ltd - dasatinib propylene glycol, quantity: 23.2 mg (equivalent: dasatinib, qty 20 mg) - tablet, film coated - excipient ingredients: lactose; croscarmellose sodium; triacetin; hydrogenated castor oil; magnesium stearate; titanium dioxide; silicon dioxide; microcrystalline cellulose; hypromellose - dasatinib dr.reddy's is indicated for the treatment of adults aged 18 years or over with: ? newly diagnosed philadelphia chromosome positive (ph+) chronic myeloid leukaemia in the chronic phase. ? chronic, accelerated or myeloid or lymphoid blast phase chronic myeloid leukaemia with resistance or intolerance to prior therapy including imatinib. ? newly diagnosed philadelphia chromosome positive acute lymphoblastic leukaemia integrated with chemotherapy. ? philadelphia chromosome positive acute lymphoblastic leukaemia with resistance or intolerance to prior therapy.,dasatinib dr.reddy's is indicated for the treatment of paediatric patients with: ? ph+ cml in the chronic phase. ? newly diagnosed ph+ all in combination with chemotherapy.

DASATINIB DR.REDDY'S dasatinib 70 mg film coated tablet blister pack Australia - English - Department of Health (Therapeutic Goods Administration)

dasatinib dr.reddy's dasatinib 70 mg film coated tablet blister pack

dr reddys laboratories australia pty ltd - dasatinib propylene glycol, quantity: 81.2 mg (equivalent: dasatinib, qty 70 mg) - tablet, film coated - excipient ingredients: silicon dioxide; croscarmellose sodium; magnesium stearate; triacetin; titanium dioxide; microcrystalline cellulose; lactose; hydrogenated castor oil; hypromellose - dasatinib dr.reddy's is indicated for the treatment of adults aged 18 years or over with: ? newly diagnosed philadelphia chromosome positive (ph+) chronic myeloid leukaemia in the chronic phase. ? chronic, accelerated or myeloid or lymphoid blast phase chronic myeloid leukaemia with resistance or intolerance to prior therapy including imatinib. ? newly diagnosed philadelphia chromosome positive acute lymphoblastic leukaemia integrated with chemotherapy. ? philadelphia chromosome positive acute lymphoblastic leukaemia with resistance or intolerance to prior therapy.,dasatinib dr.reddy's is indicated for the treatment of paediatric patients with: ? ph+ cml in the chronic phase. ? newly diagnosed ph+ all in combination with chemotherapy.

DASATINIB DR.REDDY'S dasatinib 50 mg film coated tablet blister pack Australia - English - Department of Health (Therapeutic Goods Administration)

dasatinib dr.reddy's dasatinib 50 mg film coated tablet blister pack

dr reddys laboratories australia pty ltd - dasatinib propylene glycol, quantity: 58 mg (equivalent: dasatinib, qty 50 mg) - tablet, film coated - excipient ingredients: microcrystalline cellulose; croscarmellose sodium; hydrogenated castor oil; magnesium stearate; hypromellose; titanium dioxide; lactose; triacetin; silicon dioxide - dasatinib dr.reddy's is indicated for the treatment of adults aged 18 years or over with: ? newly diagnosed philadelphia chromosome positive (ph+) chronic myeloid leukaemia in the chronic phase. ? chronic, accelerated or myeloid or lymphoid blast phase chronic myeloid leukaemia with resistance or intolerance to prior therapy including imatinib. ? newly diagnosed philadelphia chromosome positive acute lymphoblastic leukaemia integrated with chemotherapy. ? philadelphia chromosome positive acute lymphoblastic leukaemia with resistance or intolerance to prior therapy.,dasatinib dr.reddy's is indicated for the treatment of paediatric patients with: ? ph+ cml in the chronic phase. ? newly diagnosed ph+ all in combination with chemotherapy.

DR.ALTHEA PREMIUM INTENSIVE ESSENCE MASK- glycerin gel United States - English - NLM (National Library of Medicine)

dr.althea premium intensive essence mask- glycerin gel

dr. althea - dimethicone (unii: 92ru3n3y1o) (dimethicone - unii:92ru3n3y1o) - dr. althea premium intensive essence mask is a fast absorbing moisturizer that instantly hydrates the skin and improves the overall radiance. it restores elasticity and suppleness and gives a stunning glow on the face. [how to use] after prepping cleansed face with a toner, apply an appropriate amount of essence mask on the face and gently massage it until it is fully absorbed into the skin. considering the skin restoring cycle and for full benefits, use 3~4 pouches a week for four consecutive weeks.

DR GERHARD MANN CHEM-PHARM FABRIK VIDISEPT N EYE DROPS 50 mgml Singapore - English - HSA (Health Sciences Authority)

dr gerhard mann chem-pharm fabrik vidisept n eye drops 50 mgml

bausch & lomb (singapore) private limited - ophthalmology - dry eye, keratoconjunctivitis sicca; common place eye infections of all types; irritations due to dust, smoke of light; drying of the cornea due to heat or wind; corneal erosion; prophylaxis of catarrhal diseases of conjunctiva.